Rodrigo
Entrialgo Cadierno
Postdoctoral
Instituto Valenciano de Oncologia
Valencia, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto Valenciano de Oncologia (1)
2023
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1